Hirsch DR - Search Results

1

Prevalence of deep venous thrombosis among patients in medical intensive care.

Hirsch DR, Ingenito EP, Goldhaber SZ. Hirsch DR, et al. JAMA. 1995 Jul 26;274(4):335-7. JAMA. 1995. PMID: 7609264

2

Program for the prevention of venous thromboembolism in high-risk orthopaedic patients.

Reis SE, Hirsch DR, Wilson MG, Donovan BC, Goldhaber SZ. Reis SE, et al. Among authors: hirsch dr. J Arthroplasty. 1991;6 Suppl:S11-6. doi: 10.1016/s0883-5403(08)80050-2. J Arthroplasty. 1991. PMID: 1774565

3

Frequency of deep venous thrombosis in asymptomatic patients with coronary artery bypass grafts.

Reis SE, Polak JF, Hirsch DR, Cohn LH, Creager MA, Donovan BC, Goldhaber SZ. Reis SE, et al. Among authors: hirsch dr. Am Heart J. 1991 Aug;122(2):478-82. doi: 10.1016/0002-8703(91)91004-7. Am Heart J. 1991. PMID: 1858629

4

Prolonged bleeding time as a marker of venous clot lysis during streptokinase therapy.

Hirsch DR, Reis SE, Polak JF, Donovan BC, Goldhaber SZ. Hirsch DR, et al. Am Heart J. 1991 Oct;122(4 Pt 1):965-71. doi: 10.1016/0002-8703(91)90459-u. Am Heart J. 1991. PMID: 1927883

5

Prevention of venous thrombosis after coronary artery bypass surgery (a randomized trial comparing two mechanical prophylaxis strategies).

Goldhaber SZ, Hirsch DR, MacDougall RC, Polak JF, Creager MA, Cohn LH. Goldhaber SZ, et al. Among authors: hirsch dr. Am J Cardiol. 1995 Nov 15;76(14):993-6. doi: 10.1016/s0002-9149(99)80282-3. Am J Cardiol. 1995. PMID: 7484878 Clinical Trial.

6

Shortened hospitalization by means of adjusted-dose subcutaneous heparin for deep venous thrombosis.

Hirsch DR, Lee TH, Morrison RB, Carlson W, Goldhaber SZ. Hirsch DR, et al. Am Heart J. 1996 Feb;131(2):276-80. doi: 10.1016/s0002-8703(96)90354-3. Am Heart J. 1996. PMID: 8579021

7

Pulmonary embolism and deep venous thrombosis during pregnancy or oral contraceptive use: prevalence of factor V Leiden.

Hirsch DR, Mikkola KM, Marks PW, Fox EA, Dorfman DM, Ewenstein BM, Goldhaber SZ. Hirsch DR, et al. Am Heart J. 1996 Jun;131(6):1145-8. doi: 10.1016/s0002-8703(96)90089-7. Am Heart J. 1996. PMID: 8644593

8

Bolus recombinant urokinase versus heparin in deep venous thrombosis: a randomized controlled trial.

Goldhaber SZ, Hirsch DR, MacDougall RC, Polak JF, Creager MA. Goldhaber SZ, et al. Among authors: hirsch dr. Am Heart J. 1996 Aug;132(2 Pt 1):314-8. doi: 10.1016/s0002-8703(96)90427-5. Am Heart J. 1996. PMID: 8701892 Clinical Trial.

9

Contemporary use of laboratory tests to monitor safety and efficacy of thrombolytic therapy.

Hirsch DR, Goldhaber SZ. Hirsch DR, et al. Chest. 1992 Apr;101(4 Suppl):98S-105S. doi: 10.1378/chest.101.4_supplement.98s. Chest. 1992. PMID: 1555485 Review. No abstract available.

10

Laboratory parameters to monitor safety and efficacy during thrombolytic therapy.

Hirsch DR, Goldhaber SZ. Hirsch DR, et al. Chest. 1991 Apr;99(4 Suppl):113S-120S. doi: 10.1378/chest.99.4.113s. Chest. 1991. PMID: 2009807 Review.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

39 results

Search Page

Filters